Amphetamine-like discriminative stimulus effects of ephedrine and its stereoisomers in pigeons

Experimental and Clinical Psychopharmacology

Volumn 11, Issue 1, 2003, Pages 3-8

  Ercil, N Eser ^a   France, Charles P ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COCAINE; DOPAMINE RECEPTOR BLOCKING AGENT; EPHEDRINE; HALOPERIDOL; PHENTOLAMINE; PROPRANOLOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG POTENCY; NEUROCHEMISTRY; NONHUMAN; NORADRENERGIC SYSTEM; PIGEON; STEREOCHEMISTRY; STEREOISOMERISM;

EID: 0037328816     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.11.1.3     Document Type: Article

References (34)

1. Angrist, B., Rotrosen, J., Kleinberg, D., Merriam, V., & Gershon, S. (1977). Dopaminergic agonist properties of ephedrine: Theoretical implications. Psychopharmacology, 55, 115-120.
2. Briscoe, R. J., Vanecek, S. A., Vallett, M., Baird, T. J., Holloway, F. A., & Gauvin, D. V. (1998). Reinforcing effects of caffeine, ephedrine, and their binary combination in rats. Pharmacology Biochemistry and Behavior, 60, 685-693.
3. Chait, L. D. (1994). Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology, 113, 381-387.
4. Chen, K. K., & Schmidt, C. F. (1930). Ephedrine and related substances. Medicine, 9, 1-117.
5. Cheng, H. C., & Long, J. P. (1974). Dopaminergic nature of apomorphine-induced pecking in pigeons. European Journal of Pharmacology, 26, 313-320.
6. Cockings, J. G. L., & Brown, M. A. (1997). Ephedrine abuse causing acute myocardial infarction. Medical Journal of Australia, 167, 199-200.
7. Colpaert, F. C., Niemegeers, C. J., & Janssen, P. A. (1978). Discriminative stimulus properties of cocaine and d-amphetamine and antagonism by haloperidol: A comparative study. Neuropharmacology, 17, 937-942.
8. de la Garza, R., Evans, S., & Johanson, C. E. (1987). Discriminative stimulus properties of oxazepam in the pigeon. Life Science, 5, 71-79.
9. Durel, L. A., Drantz, D. S., & Barrett, J. E. (1986). The antianxiety effects of beta-blockers on punished responding. Pharmacology Biochemistry and Behavior, 25, 371-374.
10. Gauvin, D. V., Moore, K. R., Youngblood, B. D., & Holloway, F. A. (1993). The discriminative stimulus properties of legal, over-the-counter stimulants administered singly and in binary and ternary combinations. Psychopharmacology, 110, 309-319.
11. Glennon, R. A., & Young, R. (2000). (+)Amphetamine-stimulus generalization to an herbal ephedrine product. Pharmacology Biochemistry and Behavior, 65, 655-658.
12. Griffiths, R. R., Brady, J. V., & Bradford, L. D. (1979). Predicting the abuse liability of drugs with animal drug self-administration procedures: Psychomotor stimulants and hallucinogens. In T. Thompson & P. B. Dews (Eds.), Advances in behavioral pharmacology (Vol. 2, pp. 163-208). New York: Academic Press.
13. Holloway, F. A., Michaelis, R. C., & Huerta, P. L. (1985). Caffeine-phenylethylamine combinations mimic the amphetamine discriminative cue. Life Science, 36, 723-730.
14. Huang, J.-T., & Ho, B. T. (1994). Discriminative stimulus properties of d-amphetamine and related compounds in rats. Pharmacology Biochemistry and Behavior, 2, 669-673.
15. Huang, K. C. (1993). The pharmacology of Chinese herbs. Boca Raton, FL: CRC Press.
16. Jarbe, T. U. (1982) Discriminative stimulus properties of d-amphetamine in pigeons. Pharmacology Biochemistry and Behavior, 17, 671-675.
17. Kalix, P. (1991). The pharmacology of psychoactive alkaloids from Ephedra and Catha. Journal of Ethnopharmacology, 32, 201-208.
18. Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245-258.
19. McKenna, M. L., & Ho, B. T. (1980). The role of dopamine in the discriminative stimulus properties of cocaine. Neuropharmacology, 19, 297-303.
20. National Research Council. (1996). Guide for the care and use of laboratory animals. Washington, DC: National Academy Press.
21. Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001). Amphetaminetype central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse, 39, 32-41.
22. Schechter, M. D. (1980). Effects of neuroleptics and tricyclic antidepressants upon d-amphetamine discrimination. Pharmacology Biochemistry and Behavior, 12, 1-5.
23. Schechter, M. D., & Cook, P. G. (1975). Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats. Psychopharmacologia, 42, 185-193.
24. Snodgrass, S. H., & McMillan, D. E. (1991). Effects of schedule of reinforcement on a pentobarbital discrimination in rats. Journal of the Experimental Analysis of Behavior, 56, 313-329.
25. Walker, R. B., Fitz, L. D., Williams, L. M., Linton, H., Jr., & Smith, C. C. (1993). The effects of ephedrine isomers and their oxzolidines on locomotor activity in rats. General Pharmacology, 24, 669-673.
26. Wellman, P. J., Miller, D. K., Livermore, C. L., Green, T. A., McMahon, L. R., & Nation, J. R. (1998). Effects of (-)-ephedrine on locomotion, feeding, and nucleus accumbens dopamine in rats. Psychopharmacology, 125, 133-140.
27. Winger, G., Rowlett, J. K., Woolverton, W. L., France, C. P., & Gerak, L. R. (1998). Progress report from the testing program for stimulant and depressant drugs. (1998). In L. S. Harris (Ed.), Proceedings from the annual meeting of the College on Problems of Drug Dependence (NIDA Research Monograph No. 179, pp. 381-392). Washington, DC: U.S. Government Printing Office.
28. Young, R., Bondarev, M., & Glennon, R. A. (1999). An examination of isomeric phenylpropanolamines in (-)ephedrinetrained rats. Drug and Alcohol Dependence, 57, 1-6.
29. Young, R., Gabryszuk, M., & Glennon, R. A. (1998). (-)Ephedrine and caffeine mutually potentiate one another's amphetamine-like stimulus effects. Pharmacology Biochemistry and Behavior, 61, 169-173.
30. Young, R., & Glennon, R. A. (1998). Discriminative stimulus properties of (-)-ephedrine. Pharmacology Biochemistry and Behavior, 60, 771-775.
31. Young, R., & Glennon, R. A. (2000). Stimulus effects of phenylpropanolamine optical isomers in (+)-amphetamine-trained rats. Pharmacology Biochemistry and Behavior, 66, 489-494.
32. Zahn, K. A., Li, R. L., & Purssell, R. A. (1999). Cardiovascular toxicity after ingestion of 'herbal ecstasy.' Journal of Emergency Medicine, 17, 189-291.
33. Zarrindast, M. R. (1981). Dopamine-like properties of ephedrine in rat brain. British Journal of Pharmacology, 74, 119-122.
34. Zarrindast, M. R., & Namdari, S. (1992). Ephedrine and amphetamine induced pecking in chickens: Possible indirect D-I/D-2 dopaminergic mechanism. European Journal of Neuropsychopharmacology, 2, 135-140.